Dr. Aaron Clayton Campini, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1359 Main Rd, Tiverton, RI 02878 Phone: 401-624-9177 |
Dr. Norman A Cote, DDS Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 1061 Fish Rd, Tiverton, RI 02878 Phone: 401-624-6674 Fax: 401-624-6674 |
Dr. Rachel G Neal, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1359 Main Rd, Tiverton, RI 02878 Phone: 401-624-9177 |
Dr. James E Hitchen, DDS Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 1061 Fish Rd, Tiverton, RI 02878 Phone: 401-624-6676 Fax: 401-624-7667 |
John Scott Kelchner, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1061 Fish Road, Tiverton, RI 02878 Phone: 401-624-6691 |
Dr. Jonpaul Vanregenmorter, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1359 Main Rd, Tiverton, RI 02878 Phone: 401-624-9177 Fax: 401-624-9233 |
David Alan Hadad, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1061 Fish Rd, Tiverton, RI 02878 Phone: 401-624-2901 Fax: 401-624-6446 |
Dr. Kay Jenkins, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1750 Main Rd, Tiverton, RI 02878 Phone: 401-624-2375 |
Paul E Bazzoni, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1750 Main Rd, Tiverton, RI 02878 Phone: 401-624-2375 |
Roderick William Butlin, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1061 Fish Road, Tiverton, RI 02878 Phone: 401-624-2901 Fax: 401-624-6446 |
News Archive
The U.S. Food and Drug Administration (FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adults with resistance to an NNRTI and other antiretroviral (ARV) agents.
The proportion of all substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers rose by over 400 percent from 2.2 percent in 1998 to 9.8 percent in 2008 according to a new study be the Substance Abuse and Mental Health Services Administration (SAMHSA). This dramatic rise in the proportion of admissions associated with the abuse of these drugs occurred among nearly all segments of the population regardless of age, gender, educational level and employment status.
Today, the National Medical Association (NMA) and the National Black Nurses Association (NBNA) released a consensus report on RSV. Concerned that recent clinical guidelines published by the American Academy of Pediatrics Committee of Infectious Disease (AAP/COID) may leave some infants unprotected from RSV, the NMA/NBNA RSV Consensus Panel recommended that additional research be conducted to ensure that physicians provide the maximum protection to infants and children at risk of RSV.
One day, a wearable, bioelectronic device could wirelessly transmit a person's vital signs - potentially providing critical information for early detection of health issues such as COVID-19 or heart disease - to a healthcare provider, eliminating the need for an in-person visit while also saving lives.
A clinical diagnosis of depression (i.e. major depressive disorder) is currently defined on the basis of reported symptoms.
› Verified 4 days ago